Angiopoietin-1 protects against airway inflammation and hyperreactivity in asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 177, Issue 12, 2008, Pages 1314-1321

  Simoes, Davina C M ^a   Vassilakopoulos, Theodoros ^a   Toumpanakis, Dimitrios ^a   Petrochilou, Kalomira ^a   Roussos, Charis ^a   Papapetropoulos, Andreas ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Airway resistance; Eotaxin; Interleukin 5; Nuclear factor B; VCAM 1

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN RECEPTOR; EOTAXIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 13; INTERLEUKIN 5; MESSENGER RNA; OVALBUMIN; PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; CYTOKINE; IMMUNOGLOBULIN E;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ASTHMA; BINDING AFFINITY; BRONCHUS HYPERREACTIVITY; CHEMICAL ANALYSIS; CONTROLLED STUDY; HISTOLOGY; LUNG COMPLIANCE; LUNG FUNCTION; LUNG INFILTRATE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; AIRWAY RESISTANCE; ANIMAL; BAGG ALBINO MOUSE; BLOOD; DRUG EFFECT; EVALUATION; IMMUNOLOGY; LUNG LAVAGE; METABOLISM; PATHOPHYSIOLOGY;

AIRWAY RESISTANCE; ANGIOPOIETIN-1; ANIMALS; ASTHMA; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE FLUID; CYTOKINES; IMMUNOGLOBULIN E; INTERLEUKIN-5; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; OVALBUMIN; VASCULAR CELL ADHESION MOLECULE-1;

EID: 44949242413     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200708-1141OC     Document Type: Article

References (50)

1. Bousquet J, Jeffery PK, Busse WW, Johnson M, Vignola AM. Asthma: from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 2000;161:1720-1745.
2. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Annu Rev Immunol 2004;22:789-815.
3. Elias JA, Lee CG, Zheng T, Ma B, Homer RJ, Zhu Z. New insights into the pathogenesis of asthma. J Clin Invest 2003;111:291-297.
4. Vignola AM, Mirabella F, Costanzo G, Di Giorgi R, Gjomarkaj M, Bellia V, Bonsignore G. Airway remodeling in asthma. Chest 2003;123:417S-422S.
5. Feltis BN, Wignarajah D, Zheng L, Ward C, Reid D, Harding R, Walters EH. Increased vascular endothelial growth factor and receptors: relationship to angiogenesis in asthma. Am J Respir Crit Care Med 2006;173:1201-1207.
6. Hoshino M, Takahashi M, Aoike N. Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. J Allergy Clin Immunol 2001;107:295-301.
7. Lee CG, Link H, Baluk P, Homer RJ, Chapoval S, Bhandari V, Kang MJ, Cohn L, Kim YK, McDonald DM, et al. Vascular endothelial growth factor (VEGF) induces remodeling and enhances TH2-mediated sensitization and inflammation in the lung. Nat Med 2004;10:1095-1103.
8. Lee Y, Lee H. Vascular endothelial growth factor in patients with acute asthma. J Allergy Clin Immunol 2001;107:1106-1108.
9. Lee YC, Kwak Y-G, Song CH. Contribution of vascular endothelial growth factor to airway hyperresponsiveness and inflammation in a murine model of toluene diisocyanate-induced asthma. J Immunol 2002;168:3595-3600.
10. Wilson J, Hii S. The importance of the airway microvasculature in asthma. Curr Opin Allergy Clin Immunol 2006;6:51-55.
11. Hashimoto M, Tanaka H, Abe S. Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD. Chest 2005;127:965-972.
12. Salvato G. Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects. Thorax 2001;56:902-906.
13. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000;407:242-248.
14. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 1996;87:1161-1169.
15. Thurston G, Rudge JS, Ioffe E, Zhou H, Ross L, Croll SD, Glazer N, Holash J, McDonald DM, Yancopoulos GD. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 2000;6:460-463.
16. Tsigkos S, Koutsilieris M, Papapetropoulos A. Angiopoietins in angiogenesis and beyond. Expert Opin Investig Drugs 2003;12:933-941.
17. Feistritzer C, Mosheimer BA, Sturn DH, Bijuklic K, Patsch JR, Wiedermann CJ. Expression and function of the angiopoietin receptor Tie-2 in human eosinophils. J Allergy Clin Immunol 2004;114:1077-1084.
18. Lemieux C, Maliba R, Favier J, Theoret J-F, Merhi Y, Sirois MG. Angiopoietins can directly activate endothelial cells and neutrophils to promote proinflammatory responses. Blood 2005;105:1523-1530.
19. Bhandari V, Choo-Wing R, Lee CG, Zhu Z, Nedrelow JH, Chupp GL, Zhang X, Matthay MA, Ware LB, Homer RJ, et al. Hyperoxia causes angiopoietin 2-mediated acute lung injury and necrotic cell death. Nat Med 2006;12:1286-1293.
20. McCarter SD, Mei SHJ, Lai PFH, Zhang QW, Parker CH, Suen RS, Hood RD, Zhao YD, Deng Y, Han RNN, et al. Cell-based angiopoietin-1 gene therapy for acute lung injury. Am J Respir Crit Care Med 2007;175:1014-1026.
21. Roviezzo F, Tsigkos S, Kotanidou A, Bucci M, Brancaleone V, Cirino G, Papapetropoulos A. Angiopoietin-2 causes inflammation in vivo by promoting vascular leakage. J Pharmacol Exp Ther 2005;314:738-744.
22. Kim I, Moon S-O, Park SK, Chae SW, Koh GY. Angiopoietin-1 reduces VEGF-stimulated leukocyte adhesion to endothelial cells by reducing ICAM-1, VCAM-1, and E-selectin expression. Circ Res 2001;89:477-479.
23. Pizurki L, Zhou Z, Glynos K, Roussos C, Papapetropoulos A. Angiopoietin-1 inhibits endothelial permeability, neutrophil adherence and IL-8 production. Br J Pharmacol 2003;139:329-336.
24. Busse WW, Lemanske RF. Asthma. N Engl J Med 2001;344:350-362.
25. Kasama T, Isozaki T, Odai T, Matsunawa M, Wakabayashi K, Takeuchi HT, Matsukura S, Adachi M, Tezuka M, Kobayashi K. Expression of angiopoietin-1 in osteoblasts and its inhibition by tumor necrosis factor-alpha and interferon-gamma. Transl Res 2007;149:265-273.
26. Nishishita T, Lin P. Angiopoietin 1, PDGF-B, and TGF-β gene regulation in endothelial cell and smooth muscle cell interaction. J Cell Biochem 2004;91:584-593.
27. Ferrara N, Gerber H-P, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003;9:669-676.
28. Simoes D, Papapetropoulos A, Roussos C, Gratziou C. Angiopoietin 1 expression is reduced in a mouse model of asthma [abstract]. Eur Res J 2006;(Suppl 50):551S.
29. Simoes D, Vassilakopoulos T, Petrochilou K, Roussos C, Papapetropoulos A. The anti-inflammatory effects of angiopoietin-1 in mice asthma. Eur Res J 2007;S51:680s.
30. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 1992;72:168-178.
31. Jia G-Q, Gonzalo J-A, Hidalgo A, Wagner D, Cybulsky M, Gutierrez-Ramos JC. Selective eosinophil transendothelial migration triggered by eotaxin via modulation of Mac-1/ICAM-1 and VLA-4/VCAM-1 interactions. Int Immunol 1999;11:1-10.
32. Hughes DP, Marron MB, Brindle NPJ. The antiinflammatory endothelial tyrosine kinase Tie2 interacts with a novel nuclear factor-κB inhibitor ABIN-2. Circ Res 2003;92:630-636.
33. Gamble J, Drew J, Tresize L, Underwood A, Parsons M, Kasminkas L, Rudge J, Yancopoulos G, Vadas M. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cells junctions. Circ Res 2000;87:603-607.
34. Krikun G, Sakkas D, Schatz F, Buchwalder L, Hylton D, Tang C, Lockwood CJ. Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol 2004;164:2101-2107.
35. Ricciardolo FLM, Sterk PJ, Gaston B, Folkerts G. Nitric oxide in health and disease of the respiratory system. Physiol Rev 2004;84:731-765.
36. Witzenbichler B, Westermann D, Knueppel S, Schultheiss H-P, Tschope C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 2005;111:97-105.
37. Rothenberg ME, MacLean JA, Pearlman E, Luster AD, Leder P. Targeted disruption of the chemokine eotaxin partially reduces antigen-induced tissue eosinophilia. J Exp Med 1997;185:785-790.
38. Tomioka S, Bates JHT, Irvin CG. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol 2002;93:263-270.
39. Wagers S, Lundblad LKA, Ekman M, Irvin CG, Bates JHT. The allergic mouse model of asthma: normal smooth muscle in an abnormal lung? J Appl Physiol 2004;96:2019-2027.
40. Lundblad LKA, Thompson-Figueroa J, Allen GB, Rinaldi L, Norton RJ, Irvin CG, Bates JHT. Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med 2007;175:768-774.
41. Wagers SS, Norton RJ, Rinaldi LM, Bates JHT, Sobel BE, Irvin CG. Extravascular fibrin, plasminogen activator, plasminogen activator inhibitors, and airway hyperresponsiveness. J Clin Invest 2004;114:104-111.
42. Matthay MA, Clements JA. Coagulation-dependent mechanisms and asthma. J Clin Invest 2004;114:20-23.
43. Bates JHT, Mitzner W. Point: counterpoint: lung impedance measurements are/are not more useful than simpler measurements of lung function in animal models of pulmonary disease. J Appl Physiol 2007;103:1900-1901.
44. McDonald DM. Angiogenesis and remodeling of airway vasculature in chronic inflammation. Am J Respir Crit Care Med 2001;164:S39-S45.
45. King GG, Eberl S, Salome CM, Meikle SR, Woolcock AJ. Airway closure measured by a Technegas bolus and SPECT. Am J Respir Crit Care Med 1997;155:682-688.
46. Tgavalekos NT, Musch G, Harris RS, Vidal Melo MF, Winkler T, Schroeder T, Callahan R, Lutchen KR, Venegas JG. Relationship between airway narrowing, patchy ventilation and lung mechanics in asthmatics. Eur Respir J 2007;29:1174-1181.
47. Venegas JG, Winkler T, Musch G, Vidal Melo MF, Layfield D, Tgavalekos N, Fischman AJ, Callahan RJ, Bellani G, Scott Harris R. Self-organized patchiness in asthma as a prelude to catastrophic shifts. Nature 2005;434:777-782.
48. Harris RS, Winkler T, Tgavalekos N, Musch G, Melo MFV, Schroeder T, Chang Y, Venegas JG. Regional pulmonary perfusion, inflation, and ventilation defects in bronchoconstricted patients with asthma. Am J Respir Crit Care Med 2006;174:245-253.
49. Laurent F, Latrabe V, Raherison C, Marthan R, Tunon-de-Lara JM. Functional significance of air trapping detected in moderate asthma. Eur Radiol 2000;10:1404-1410.
50. Kanazawa H, Nomura S, Asai K. Roles of angiopoietin-1 and angiopoietin-2 on airway microvascular permeability in asthmatic patients. Chest 2007;131:1035-1041.